New drug epacadostat plus pembrolizumab combination shows promise in patients with advanced kidney cancer
The results from a phase I/II clinical trial of epacadostat [...]
The results from a phase I/II clinical trial of epacadostat [...]
Scientists at The Institute of Cancer Research (ICR), London, and [...]
The first high-energy proton beam therapy system to be installed [...]
A recent study published in the journal Cancer Epidemiology by [...]
This literature review was published in The Journal of Urology [...]
Nivolumab has demonstrated a substantial objective response rate and was [...]
A recent study published in the British Journal of Cancer [...]
Recently published data from the Office for National Statistics (ONS) [...]